Worth reading
54Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Mixed performance
Direction inferred from the company’s description.Scale
4.5
% (year-on-year change in operating profit)Wording
Conditional
How definitive the wording is.Results for this period
Full year1 April 2025–31 March 2026ConsolidatedJapanese GAAPNet Sales219,140¥ millionYear on year -1.2%Progress 104.4%
Operating profit13,696¥ millionYear on year +4.5%Progress 114.1%
Ordinary income14,353¥ millionYear on year +5.6%Progress 115.8%
Net income attributable to owners of the parent9,951¥ millionYear on year +12.6%Progress 105.9%
The width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
Net income per share¥311.77
Operating Margin6.3％
Financial position at period-end
Total assets175,639¥ million
of which net assets 90,701 ¥ millionEquity ratio 51.5%vs. prior year-end +5.0pt
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Cash inflows and outflows
Operating+16,136
Investment-188
Financials+1,221
Net change+17,169
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Cash and cash equivalents at end of period¥51,829 million
Segment revenue
Plant and Energy Business22,41510.2%-6.0%
Energy Solutions Business40,04418.3%-26.0%
Industrial-Machinery Business27,21012.4%-7.8%
Electronics Business51,07323.3%+2.1%
Automotive Business42,50819.4%+4.3%
Healthcare Business23,82610.9%+51.4%
Aerospace and Infrastructure Business11,9905.5%+57.0%
Segment profit
Plant and Energy Business1,62511.8%-11.8%
Energy Solutions Business2,64419.2%-1.5%
Industrial-Machinery Business7405.4%-16.9%
Electronics Business2,74719.9%+2.0%
Automotive Business2,58118.7%+18.1%
Healthcare Business2,40017.4%+44.9%
Aerospace and Infrastructure Business1,0497.6%+105.2%
Outlook and shareholder returns
Full-year earnings forecast
Net Sales¥210,000 million (YoY -4.2%)
Operating profit¥12,000 million (YoY -12.4%)
Ordinary income¥12,400 million (YoY -13.6%)
Net income¥9,400 million (YoY -5.5%)
Annual Dividend Forecast¥92 → ¥125
Payout ratioFiscal year ending March 2026 40.1 / Forecast for the fiscal year ending March 2027 42.5
Factors Behind Changes in Business Performance
Although sales of medical equipment manufacturing systems and aircraft ground support equipment for airlines increased significantly, sales of lithium-ion battery manufacturing equipment and other products for domestic and overseas markets declined. Progress in improving the gross margin absorbed the increase in selling, general and administrative expenses.
Disclosure regarding the going concern assumption
None. The notes regarding the going concern assumption state, “There are no applicable matters.”
Change in accounting policy
基準改正に伴う変更 Noそれ以外の変更 No見積りの変更 No修正再表示 No
Changes in the scope of consolidationNew 0 / Excluded 0 / Company name None
Material subsequent eventsNot applicable.
Breakdown of extraordinary income (loss)Extraordinary income Gain on sale of investment securities ¥458 million / Extraordinary loss Impairment loss on investment securities ¥145 million, Impairment loss on membership rights ¥2 million
Depreciation and amortization¥1,155 million
Orders received and order backlogOrders received 2,700 Hundreds of millions of yen / Order backlog Not disclosed
Availability of Supplementary Financial Results MaterialsYes
Availability of Financial Results BriefingWhether applicable Yes / Subject person Institutional investors and analysts
Issued Shares at Period-End32,759,200
Treasury Shares at Period-End830,307
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 April 2025–31 March 2026 |
| Net Sales | ¥219,140 million (YoY -1.2%) |
| Operating profit | ¥13,696 million (YoY +4.5%) |
| Ordinary income | ¥14,353 million (YoY +5.6%) |
| Profit attributable to owners of the parent | ¥9,951 million (YoY +12.6%) |
| Net income per share | ¥311.77 |
| Operating Margin | 6.3％ |
| Equity ratio | End of the current fiscal period 51.5 / End of previous period 46.5 |
| Total assets | ¥175,639 million |
| Net assets | ¥90,701 million |
| Cash flows from operating activities | ¥16,136 million |
| Cash flows from investing activities | ¥-188 million |
| Cash flows from financing activities | ¥1,221 million |
| Cash and cash equivalents at end of period | ¥51,829 million |
| Full-year earnings forecast | Net Sales ¥210,000 million (YoY -4.2%) / Operating profit ¥12,000 million (YoY -12.4%) / Ordinary income ¥12,400 million (YoY -13.6%) / Net income ¥9,400 million (YoY -5.5%) |
| Annual Dividend Forecast | ¥92 → ¥125 |
| Payout ratio | Fiscal year ending March 2026 40.1 / Forecast for the fiscal year ending March 2027 42.5 |
| Segment revenue | Plant and Energy Business ¥22,415 million (YoY -6.0%) / Energy Solutions Business ¥40,044 million (YoY -26.0%) / Industrial-Machinery Business ¥27,210 million (YoY -7.8%) / Electronics Business ¥51,073 million (YoY +2.1%) / Automotive Business ¥42,508 million (YoY +4.3%) / Healthcare Business ¥23,826 million (YoY +51.4%) / Aerospace and Infrastructure Business ¥11,990 million (YoY +57.0%) |
| Segment profit | Plant and Energy Business ¥1,625 million (YoY -11.8%) / Energy Solutions Business ¥2,644 million (YoY -1.5%) / Industrial-Machinery Business ¥740 million (YoY -16.9%) / Electronics Business ¥2,747 million (YoY +2.0%) / Automotive Business ¥2,581 million (YoY +18.1%) / Healthcare Business ¥2,400 million (YoY +44.9%) / Aerospace and Infrastructure Business ¥1,049 million (YoY +105.2%) |
| Orders received and order backlog | Orders received 2,700 Hundreds of millions of yen / Order backlog Not disclosed |
| Depreciation and amortization | ¥1,155 million |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥458 million / Extraordinary loss Impairment loss on investment securities ¥145 million, Impairment loss on membership rights ¥2 million |
| Disclosure regarding the going concern assumption | None. The notes regarding the going concern assumption state, “There are no applicable matters.” |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | New 0 / Excluded 0 / Company name None |
| Material subsequent events | Not applicable. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Whether applicable Yes / Subject person Institutional investors and analysts |
| Issued Shares at Period-End | 32,759,200 |
| Treasury Shares at Period-End | 830,307 |
| Factors Behind Changes in Business Performance | Although sales of medical equipment manufacturing systems and aircraft ground support equipment for airlines increased significantly, sales of lithium-ion battery manufacturing equipment and other products for domestic and overseas markets declined. Progress in improving the gross margin absorbed the increase in selling, general and administrative expenses. |
Items this document does not state (4)
Revision to Earnings ForecastShareholder Return PolicyRegional salesImpairment loss
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.Revenue from medical equipment manufacturing systems and aircraft ground support equipment increased, while revenue from lithium-ion battery manufacturing equipment and other products declined. Operating profit increased as progress in improving the gross margin absorbed the increase in selling, general and administrative expenses.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.